Cover Image
Market Research Report

Quark Pharmaceuticals Inc - Product Pipeline Review - 2016

Published by Global Markets Direct Product code 224689
Published Content info 48 Pages
Delivery time: 1-2 business days
Price
Back to Top
Quark Pharmaceuticals Inc - Product Pipeline Review - 2016
Published: December 30, 2016 Content info: 48 Pages
Description

Summary:

Global Markets Direct's, 'Quark Pharmaceuticals Inc - Product Pipeline Review - 2016', provides an overview of the Quark Pharmaceuticals Inc's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Quark Pharmaceuticals Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the pipeline therapeutic landscape of Quark Pharmaceuticals Inc
  • The report provides overview of Quark Pharmaceuticals Inc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Quark Pharmaceuticals Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Quark Pharmaceuticals Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy:

  • Evaluate Quark Pharmaceuticals Inc's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Quark Pharmaceuticals Inc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Quark Pharmaceuticals Inc's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Product Code: GMDHC08197CDB

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Quark Pharmaceuticals Inc Snapshot
    • Quark Pharmaceuticals Inc Overview
    • Key Facts
  • Quark Pharmaceuticals Inc - Research and Development Overview
    • Key Therapeutic Areas
  • Quark Pharmaceuticals Inc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Quark Pharmaceuticals Inc - Pipeline Products Glance
    • Quark Pharmaceuticals Inc - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Quark Pharmaceuticals Inc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Quark Pharmaceuticals Inc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Quark Pharmaceuticals Inc - Drug Profiles
    • QPAL-1 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPAL-2 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPCO-1 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPCP-1 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPEN-1 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPEN-2 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPHL-1 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPHL-2 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPHL-3 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPI-1002 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPI-1007 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPI-1024 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPLI-1 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPLI-2 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • QPNR-1 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Quark Pharmaceuticals Inc - Pipeline Analysis
    • Quark Pharmaceuticals Inc - Pipeline Products by Target
    • Quark Pharmaceuticals Inc - Pipeline Products by Route of Administration
    • Quark Pharmaceuticals Inc - Pipeline Products by Molecule Type
    • Quark Pharmaceuticals Inc - Pipeline Products by Mechanism of Action
  • Quark Pharmaceuticals Inc - Dormant Projects
  • Quark Pharmaceuticals Inc - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Quark Pharmaceuticals Inc, Key Facts
  • Quark Pharmaceuticals Inc - Pipeline by Indication, 2016
  • Quark Pharmaceuticals Inc - Pipeline by Stage of Development, 2016
  • Quark Pharmaceuticals Inc - Monotherapy Products in Pipeline, 2016
  • Quark Pharmaceuticals Inc - Partnered Products in Pipeline, 2016
  • Quark Pharmaceuticals Inc - Partnered Products/ Combination Treatment Modalities, 2016
  • Quark Pharmaceuticals Inc - Out-Licensed Products in Pipeline, 2016
  • Quark Pharmaceuticals Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016
  • Quark Pharmaceuticals Inc - Phase III, 2016
  • Quark Pharmaceuticals Inc - Phase II, 2016
  • Quark Pharmaceuticals Inc - Preclinical, 2016
  • Quark Pharmaceuticals Inc - Discovery, 2016
  • Quark Pharmaceuticals Inc - Pipeline by Target, 2016
  • Quark Pharmaceuticals Inc - Pipeline by Route of Administration, 2016
  • Quark Pharmaceuticals Inc - Pipeline by Molecule Type, 2016
  • Quark Pharmaceuticals Inc - Pipeline Products by Mechanism of Action, 2016
  • Quark Pharmaceuticals Inc - Dormant Developmental Projects,2016

List of Figures

  • Quark Pharmaceuticals Inc - Pipeline by Top 10 Indication, 2016
  • Quark Pharmaceuticals Inc - Pipeline by Stage of Development, 2016
  • Quark Pharmaceuticals Inc - Monotherapy Products in Pipeline, 2016
  • Quark Pharmaceuticals Inc - Partnered Products in Pipeline, 2016
  • Quark Pharmaceuticals Inc - Pipeline by Target, 2016
  • Quark Pharmaceuticals Inc - Pipeline by Route of Administration, 2016
  • Quark Pharmaceuticals Inc - Pipeline by Top 10 Molecule Type, 2016
  • Quark Pharmaceuticals Inc - Pipeline Products by Mechanism of Action, 2016
Back to Top